Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
None on record since 2016.
Sits alongside
People who currently share a board or management team with this person.
- Alecia A. DecoudreauxCVS
- Amy Compton-PhillipsCVS
- Anne A. FinucaneCVS
- Brian NewmanCVS
- C. David Brown IICVS
- Douglas H. ShulmanCVS
- Fernando AguirreCVS
- Guy P. SansoneCVS
- Heidi B. CapozziCVS
- J. David JoynerCVS
- Jeffrey R. BalserCVS
- John E. GallinaCVS
- J. Scott KirbyCVS
- Larry RobbinsCVS
- Leslie Norwalk VCVS
- Michael F. MahoneyCVS
- Prem S. ShahCVS
- Roger N. FarahCVS
- Samrat S. KhichiCVS
- Steven H. NelsonCVS
- Tilak MandadiCVS
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2025 | CVS | Sale | 7,513 | $66.35 | $498K |
| Aug 3, 2023 | CVS | Sale | 2,631 | $74.79 | $197K |
| Aug 3, 2023 | CVS | Sale | 23,128 | $74.94 | $1.7M |
| Jan 28, 2022 | CVS | Sale | 6,059 | $109.00 | $660K |
| Mar 31, 2021 | CVS | Sale | 5,350 | $76.00 | $407K |
| May 26, 2020 | CVS | Sale | 270 | $65.00 | $18K |
| Apr 28, 2020 | CVS | Sale | 6,234 | $65.00 | $405K |
| Mar 30, 2020 | CVS | Sale | 3,030 | $60.00 | $182K |
| Mar 1, 2019 | CVS | Sale | 1,664 | $58.14 | $97K |
SEC reporting-owner ID (CIK) 1757584 · all filings on EDGAR